Elliptic Laboratories ASA
OSE:ELABS

Watchlist Manager

Elliptic Laboratories ASA

OSE:ELABS

Watchlist

Dividends

Price: 12.78 NOK 2.08% Market Closed

Market Cap: 1.3B NOK

Have any thoughts about
Elliptic Laboratories ASA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 12.78 NOK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

ELABS Alert

Elliptic Laboratories ASA

12.78

+0.26 (+2.08%)

52 Week Range	9.45 18.2
Price Target

We'll email you a reminder when the closing price reaches NOK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Elliptic Laboratories ASA

What unique competitive advantages
does Elliptic Laboratories ASA hold over its rivals?

What risks and challenges
does Elliptic Laboratories ASA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Elliptic Laboratories ASA.

What unique competitive advantages
does Elliptic Laboratories ASA hold over its rivals?

What risks and challenges
does Elliptic Laboratories ASA face in the near future?

Summarize the latest earnings call
of Elliptic Laboratories ASA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Elliptic Laboratories ASA.

Provide P/S
for Elliptic Laboratories ASA.

Provide P/E
for Elliptic Laboratories ASA.

Provide P/OCF
for Elliptic Laboratories ASA.

Provide P/FCFE
for Elliptic Laboratories ASA.

Provide P/B
for Elliptic Laboratories ASA.

Provide EV/S
for Elliptic Laboratories ASA.

Provide EV/GP
for Elliptic Laboratories ASA.

Provide EV/EBITDA
for Elliptic Laboratories ASA.

Provide EV/EBIT
for Elliptic Laboratories ASA.

Provide EV/OCF
for Elliptic Laboratories ASA.

Provide EV/FCFF
for Elliptic Laboratories ASA.

Provide EV/IC
for Elliptic Laboratories ASA.

Show me price targets
for Elliptic Laboratories ASA made by professional analysts.

What are the Revenue projections
for Elliptic Laboratories ASA?

How accurate were the past Revenue estimates
for Elliptic Laboratories ASA?

What are the Net Income projections
for Elliptic Laboratories ASA?

How accurate were the past Net Income estimates
for Elliptic Laboratories ASA?

What are the EPS projections
for Elliptic Laboratories ASA?

How accurate were the past EPS estimates
for Elliptic Laboratories ASA?

What are the EBIT projections
for Elliptic Laboratories ASA?

How accurate were the past EBIT estimates
for Elliptic Laboratories ASA?

Compare the revenue forecasts
for Elliptic Laboratories ASA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Elliptic Laboratories ASA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Elliptic Laboratories ASA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Elliptic Laboratories ASA compared to its peers.

Compare the P/E ratios
of Elliptic Laboratories ASA against its peers.

Discuss the investment returns and shareholder value creation
comparing Elliptic Laboratories ASA with its peers.

Analyze the financial leverage
of Elliptic Laboratories ASA compared to its main competitors.

Show all profitability ratios
for Elliptic Laboratories ASA.

Provide ROE
for Elliptic Laboratories ASA.

Provide ROA
for Elliptic Laboratories ASA.

Provide ROIC
for Elliptic Laboratories ASA.

Provide ROCE
for Elliptic Laboratories ASA.

Provide Gross Margin
for Elliptic Laboratories ASA.

Provide Operating Margin
for Elliptic Laboratories ASA.

Provide Net Margin
for Elliptic Laboratories ASA.

Provide FCF Margin
for Elliptic Laboratories ASA.

Show all solvency ratios
for Elliptic Laboratories ASA.

Provide D/E Ratio
for Elliptic Laboratories ASA.

Provide D/A Ratio
for Elliptic Laboratories ASA.

Provide Interest Coverage Ratio
for Elliptic Laboratories ASA.

Provide Altman Z-Score Ratio
for Elliptic Laboratories ASA.

Provide Quick Ratio
for Elliptic Laboratories ASA.

Provide Current Ratio
for Elliptic Laboratories ASA.

Provide Cash Ratio
for Elliptic Laboratories ASA.

What is the historical Revenue growth
over the last 5 years for Elliptic Laboratories ASA?

What is the historical Net Income growth
over the last 5 years for Elliptic Laboratories ASA?

What is the current Free Cash Flow
of Elliptic Laboratories ASA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Elliptic Laboratories ASA.

ELABS

Balance Sheet

Total Current Liabilities

Elliptic Laboratories ASA
Total Current Liabilities

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

Elliptic Laboratories ASA
Total Current Liabilities Peer Comparison

Comparables:

OPRA

PEXIP

LINK

SMCRT

VOLUE

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company		Total Current Liabilities	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Elliptic Laboratories ASA OSE:ELABS	Total Current Liabilities kr24.9m	CAGR 3-Years 22%	CAGR 5-Years -15%	CAGR 10-Years N/A
	Opera Ltd NASDAQ:OPRA	Total Current Liabilities $74.3m	CAGR 3-Years -2%	CAGR 5-Years 9%	CAGR 10-Years N/A
	Pexip Holding ASA OSE:PEXIP	Total Current Liabilities kr405.4m	CAGR 3-Years 7%	CAGR 5-Years 40%	CAGR 10-Years N/A
L	Link Mobility Group Holding ASA OSE:LINK	Total Current Liabilities kr1.8B	CAGR 3-Years 24%	CAGR 5-Years 27%	CAGR 10-Years N/A
S	Smartcraft ASA OSE:SMCRT	Total Current Liabilities kr205m	CAGR 3-Years 10%	CAGR 5-Years 27%	CAGR 10-Years N/A
V	Volue ASA OSE:VOLUE	Total Current Liabilities kr745.6m	CAGR 3-Years 11%	CAGR 5-Years 2%	CAGR 10-Years N/A

What is Elliptic Laboratories ASA's Total Current Liabilities?

Total Current Liabilities
24.9m NOK

Based on the financial report for Dec 31, 2023, Elliptic Laboratories ASA's Total Current Liabilities amounts to 24.9m NOK.

What is Elliptic Laboratories ASA's Total Current Liabilities growth rate?

Total Current Liabilities CAGR 5Y
-15%

Over the last year, the Total Current Liabilities growth was 45%. The average annual Total Current Liabilities growth rates for Elliptic Laboratories ASA have been 22% over the past three years , -15% over the past five years .

Elliptic Laboratories ASA
OSE:ELABS

Elliptic Laboratories ASA
Total Current Liabilities

Elliptic Laboratories ASA
Total Current Liabilities Peer Comparison

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

See Also

What is Elliptic Laboratories ASA's Total Current Liabilities?

Total Current Liabilities
24.9m NOK

What is Elliptic Laboratories ASA's Total Current Liabilities growth rate?

Total Current Liabilities CAGR 5Y
-15%

Company

Help

Tools

Stocks

Elliptic Laboratories ASA OSE:ELABS

Elliptic Laboratories ASA Total Current Liabilities

Elliptic Laboratories ASA Total Current Liabilities Peer Comparison

Competitive Total Current Liabilities Analysis Latest Figures & CAGR of Competitors

See Also

What is Elliptic Laboratories ASA's Total Current Liabilities? Total Current Liabilities 24.9m NOK

What is Elliptic Laboratories ASA's Total Current Liabilities growth rate? Total Current Liabilities CAGR 5Y -15%

Company

Help

Tools

Stocks

Elliptic Laboratories ASA
OSE:ELABS

Elliptic Laboratories ASA
Total Current Liabilities

Elliptic Laboratories ASA
Total Current Liabilities Peer Comparison

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

What is Elliptic Laboratories ASA's Total Current Liabilities?

Total Current Liabilities
24.9m NOK

What is Elliptic Laboratories ASA's Total Current Liabilities growth rate?

Total Current Liabilities CAGR 5Y
-15%